Login

Consolidated Balance Sheets

In USD, except per-share amounts
Q3 FY2021
As of Mar 31, 2021
Q2 FY2021
As of Dec 31, 2020
Q1 FY2021
As of Sep 30, 2020
Q4 FY2020
As of Jun 30, 2020
Q3 FY2020
As of Mar 31, 2020
Q2 FY2020
As of Dec 31, 2019
Q1 FY2020
As of Sep 30, 2019
Q4 FY2019
As of Jun 30, 2019
Q3 FY2019
As of Mar 31, 2019
Q2 FY2019
As of Dec 31, 2018
Q1 FY2019
As of Sep 30, 2018
Q4 FY2018
As of Jun 30, 2018
Q3 FY2018
As of Mar 31, 2018
Q2 FY2018
As of Dec 31, 2017
Q1 FY2018
As of Sep 30, 2017
Q4 FY2017
As of Jun 30, 2017
Q3 FY2017
As of Mar 31, 2017
Q2 FY2017
As of Dec 31, 2016
Q1 FY2017
As of Sep 30, 2016
Q4 FY2016
As of Jun 30, 2016
ASSETS
Current Assets:
Cash
Certificate of deposit
Receivables
Inventory, net
Investment in real estate limited partnership
Prepaid expenses
Total Current Assets
Property and Improvements:
Land
Tooling and equipment
Tooling & Equipment
Building and improvements
Property and Improvements Before Depreciation
Less, accumulated depreciation
Total Property and Improvement
Other Assets:
Investment in real estate limited partnership
Right of use asset, net
Intangible asset, net of amortization of $441,071 and $418,571, respectively
Other assets
Total Other Assets
Total Assets
LIABILITIES AND STOCKHOLDERS' DEFICIT
Current Liabilities:
Accounts payable
Current portion of convertible notes payable, net of $33,484 in deferred loan costs
Deferred revenue
Accrued liabilities
Settlement liability
Current maturities of long-term debt
Operating leases - current
Lines of credit
Insurance notes payable
Total Current Liabilities
Non-current Liabilities
Due to related parties
Other non-current liabilities
Operating lease - non-current
Real estate note payable, net of current maturities
Convertible notes payable, net of $67,107 in deferred loan costs and $25,000 of beneficial conversion at March 31, 2021 and $217,167 in deferred loan costs and $250,000 of beneficial conversion at June 30, 2020
Total Long-Term Debt
Total Liabilities
Stockholders' Deficit:
Preferred stock, value
Series A Preferred Stock
Series B Preferred Stock
Common Stock, par value of $0.001 per share, 2,000,000,000 authorized shares and 1,518,490,545 and 1,165,199,800 issued at March 31, 2021 and June 30, 2020, respectively
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Total Stockholders' Equity (Deficit) Before Treasury Stock
Stockholders' Equity Before Treasury Stock
Total Stockholders' Equity Before Treasury Stock
Less, Treasury stock 201,548,643 shares, at cost
Total Stockholders' Deficit
Total Liabilities and Stockholders' Deficit

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support